Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

US Risers & Fallers: PharmaCyte, Theralase, J.P. Morgan, MagneGas, Gold Resource, Best Buy

Best Buy shares sink after the electronics company cuts outlook following disappointing holiday sales.

Below are some of the main news-driven share price changes as at 1:03 p.m. in New York.

Risers:

PharmaCyte Biotech (OTCQB:PMCB) gained 13.2% to US$0.0791. The clinical stage development company raised a further US$1mln to advance its aims of getting into a pancreatic cancer clinical trial.

Theralase Technologies (CVE:TLT) (OTCMKTS:TLTFF) rose 4% to $0.39 after the biotechnology manufacturer said it will debut its next generation TLC-2000 Therapeutic Medical Laser System, at the Parker Seminar event in Las Vegas from January 14 to 16.

J.P. Morgan Chase (NYSE:JPM) rose 2.7% to $58.85 after the investment bank said quarterly profits rose thanks in part to higher earnings within its investment-banking division.

Fallers:

MagneGas (NASDAQ:MNGA) fell 3% to US$1.35 even as the technology company said a previously announced major waste to energy company, which had placed initial orders of MagneGas2 fuel, has now expanded the use of the fuel to multiple facilities.

Gold Resource (NYSE:GORO) fell 8.3% to $1.21 even as the mining company ended 2015 on a positive - increasing output of gold, silver, copper and zinc.

Best Buy (NYSE:BBY) sank 8.9% to $26.65 after the electronics retailer said holiday same-store sales fell 1.2% due to softer-than-expected mobile phone sales.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK